Wobble Genomics is a pioneering healthcare and biotechnology company specialising in long-read RNA sequencing. Its innovative Level-Up biochemical technology enhances the detection of low-abundance RNA sequences, allowing scientists to capture all unique full-length RNA sequences in any sample. Paired with its TAMA bioinformatic technology, Wobble optimises the identification of low-level signals, using RNA biology to drive deeper insights from sequencing data
| Website | https://www.wobblegenomics.com |
| Employees | 19 (10 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Rna Sequencing, Biotechnology, Biochemical Technology, Healthcare, Rna Analysis, Genetic Sequencing, Genome Sequencing, Molecular Diagnostics, Transcriptomics, Precision Medicine, Next Generation Sequencing, Ngs, Bioinformatics, Genomics, Dna Sequencing, Sequencing Technology |
| Competitors | Roche, Thermo Fisher Scientific, Sanofi, Agilent Technologies, Illumina, Bio-Rad Laboratories, QIAGEN, Oxford Nanopore Technologies, PacBio, Bioneer +40 more (view full list) |
Looking for a particular Wobble Genomics employee's phone or email?
Richard Kuo is the CEO of Wobble Genomics.
10 people are employed at Wobble Genomics.
Wobble Genomics is based in Edinburgh, Scotland.